In addition, it has also been demonstrated that melatonin may directly interfere with the activation of the estrogen receptor and counteract the effects of estrogens at the tumor cell level, thus behaving as a selective estrogen receptor modulator (7,9–11). The gene discussed is ESR1; the disease is neoplasm.